Given that influential pro-inflammatory cytokines IL-6, TNF-α and IFN-γ might represent important inflammatory biomarkers, and co-occurring depression might represent an inflammatory endophenotype of schizophrenia, immune-based therapies could target such biomedical profile in precision medicine studies. Here, IL6 is linked to major depressive disorder.